Journal of Ginseng Research

  • 제44권2호
  • /
  • Pages.222-228
  • /
  • 2020
  • /
  • 1226-8453(pISSN)
  • /
  • 2093-4947(eISSN)
고려인삼학회 (The Korean Society of Ginseng)
권호 표지
DOI QR코드

DOI QR Code

Acute and repeated dose 26-week oral toxicity study of 20(S)-ginsenoside Rg3 in Kunming mice and Sprague-Dawley rats

  • Li, Chunmei (School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University) ;
  • Wang, Zhezhe (School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University) ;
  • Li, Guisheng (School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University) ;
  • Wang, Zhenhua (School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University) ;
  • Yang, Jianrong (School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University) ;
  • Li, Yanshen (School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University) ;
  • Wang, Hongtao (School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University) ;
  • Jin, Haizhu (Department of Food and Biological Engineering, Wenjing College of Yantai University) ;
  • Qiao, Junhua (Yantai University Hospital, Yantai University) ;
  • Wang, Hongbo (School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University) ;
  • Tian, Jingwei (School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University) ;
  • Lee, Albert W. (NutraSource, Inc.) ;
  • Gao, Yonglin (School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University)
  • 투고 : 2018.04.29
  • 심사 : 2018.10.11
  • 발행 : 2020.03.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: 20(S)-ginsenoside-Rg3 (C42H72O13), a natural triterpenoid saponin, is extracted from red ginseng. The increasing use of 20(S)-ginsenoside Rg3 has raised product safety concerns. Methods: In acute toxicity, 20(S)-ginsenoside Rg3 was singly and orally administrated to Kunming mice and Sprague-Dawley (SD) rats at the maximum doses of 1600 mg/kg and 800 mg/kg, respectively. In the 26-week toxicity study, we used repeated oral administration of 20(S)-ginsenoside Rg3 in SD rats over 26 weeks at doses of 0, 20, 60, or 180 mg/kg. Moreover, a 4-week recovery period was scheduled to observe the persistence, delayed occurrence, and reversibility of toxic effects. Results: The result of acute toxicity shows that oral administration of 20(S)-ginsenoside Rg3 to mice and rats did not induce mortality or toxicity up to 1600 and 800 mg/kg, respectively. During a 26-week administration period and a 4-week withdrawal period (recovery period), there were no significant differences in clinical signs, body weight, food consumption, urinalysis parameters, biochemical and hematological values, or histopathological findings. Conclusion: The mean oral lethal dose (LD50) of 20(S)-ginsenoside Rg3, in acute toxicity, is above 1600 mg/kg and 800 mg/kg in mice and rats, respectively. In a repeated-dose 26-week oral toxicity study, the no-observed-adverse-effect level for female and male SD rats was 180 mg/kg.

키워드

참고문헌

  1. Gao YL, Liu ZF, Li CM, Shen JY, Yin HX, Li GS. Subchronic toxicity studies with ginsenoside compound K delivered to dogs via intravenous administration. Food Chem Toxicol 2011;49:1857-62. https://doi.org/10.1016/j.fct.2011.05.003
  2. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 2013;105:1230-8. https://doi.org/10.1093/jnci/djt181
  3. Lu H, Zhou X, Kwok HH, Dong M, Liu Z, Poon PY, Luan X, Ngok S, Wong R. Ginsenoside-Rb1-mediated anti-angiogenesis via regulating PEDF and miR- 33a through the activation of PPAR-g pathway. Front Pharmacol 2017;8:783. https://doi.org/10.3389/fphar.2017.00783
  4. Lee B, Kim H, Shim I, Lee H, Hahm DH. Wild ginseng attenuates anxiety- and depression-like behaviors during morphine withdrawal. J Microbiol Biotechnol 2011;21:1088-96. https://doi.org/10.4014/jmb.1106.06027
  5. Xie J, Shao J, Lu Y, Chen J, Wang J, Yu S, Jia L. Separation of ginseng active ingredients and their roles in cancer metastasis supplementary therapy. Curr Drug Metab 2013;14:616-23. https://doi.org/10.2174/13892002113149990003
  6. Xie Q, Wen H, Zhang Q, Zhou W, Lin X, Xie D, Liu Y. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell. Biomed Pharmacother 2017;85:16-21. https://doi.org/10.1016/j.biopha.2016.11.096
  7. Wang JH, Nao JF, Zhang M, He P. 20(S)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumour Biol 2014;35:11985-94. https://doi.org/10.1007/s13277-014-2497-5
  8. Qiu XM, Bai X, Jiang HF, He P, Wang JH. 20-(S)-Ginsenoside Rg3 induces apoptotic cell death in human leukemic U937 and HL-60 cells through PI3K/Akt pathways. Anticancer Drugs 2014;25:1072-80. https://doi.org/10.1097/CAD.0000000000000147
  9. Sin S, Kim SY, Kim SS. Chronic treatment with ginsenoside Rg3 induces Akt dependent senescence in human glioma cells. Int J Oncol 2012;41:1669-74. https://doi.org/10.3892/ijo.2012.1604
  10. Yuan Z, Jiang H, Zhu X, Liu X, Li J. Ginsenoside Rg3 promotes cytotoxicity of paclitaxel through inhibiting NF-kB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Biomed Pharmacother 2017;89:227-32. https://doi.org/10.1016/j.biopha.2017.02.038
  11. Jiang JW, Chen XM, Chen XH, Zheng SS. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol 2011;17:3605-13. https://doi.org/10.3748/wjg.v17.i31.3605
  12. Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep 2012;5:1295-8. https://doi.org/10.3892/mmr.2012.808
  13. Kim DG, Jung KH, Lee DG, Yoon JH, Choi KS, Kwon SW, Shen HM, Morgan MJ, Hong SS, Kim YS. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget 2014;5:4438-51. https://doi.org/10.18632/oncotarget.2034
  14. Liu JP, Lu D, Nicholson RC, Li PY, Wang F. Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: a 26-week intramuscular repeated administration study in Beagle dogs. Food Chem Toxicol 2011;49:1718-27. https://doi.org/10.1016/j.fct.2011.04.017
  15. Liu JP, Lu D, Nicholson RC, Zhao WJ, Li PY, Wang F. Toxicity of a novel antitumor agent 20(S)-ginsenoside Rg3: a 26-week intramuscular repeated administration study in rats. Food Chem Toxicol 2012;50:3388-96. https://doi.org/10.1016/j.fct.2012.07.004
  16. Zhang SM. Quality study of Ginsenoside-Rg3 for treating tumor. Master Dissertation: Chinese Marine University; 2004.
  17. Li YR, Wang YH, Yang XW, Zheng YN. Analysis of saponins in black red ginseng by HPLC-MS/MS. Chin J Pharm Anal 2013;33(5):812-7.
  18. CFDA. 2003. http://samr.cfda.gov.cn/WS01/CL0053/24472.html.
  19. CFDA. Guidelines for acute toxicity studies in the rodent [Z]GPT2-1. 2005.
  20. CFDA. Guidelines for subchronic toxicity studies in the rodent [Z]GPT3-1. 2005.
  21. Jordan SA, Cunningham DG, Marles R. Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 2010;243:198-216. https://doi.org/10.1016/j.taap.2009.12.005
  22. Li G, Yang M, Hao X, Li C, Gao Y, Tao J. Acute toxicity of sodium formononetin-3'- sulphonate (Sul-F) in Sprague-Dawley rats and Beagle dogs. Regul Toxicol Pharmacol 2015;72:629-33.
  23. Li C, Li G, Gao Y, Sun C, Wang X. A 90-day subchronic toxicity study with sodium formononetin-3'-sulphonate (Sul-F) delivered to dogs via intravenous administration. Regul Toxicol Pharmacol 2016;77:87-92. https://doi.org/10.1016/j.yrtph.2016.02.016
  24. Brown AC. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food Chem Toxicol 2017;107(Pt A):449-71. https://doi.org/10.1016/j.fct.2016.11.001
  25. Park SJ, Noh J, Jeong EJ, Kim YS, Han BC, Lee SH, Moon KS. Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period. Regul Toxicol Pharmacol 2018;92:83-93. https://doi.org/10.1016/j.yrtph.2017.11.007
  26. Chan PC, Peckham JC, Malarkey DE, Kissling GE, Travlos GS, Fu PP. Two-year toxicity and carcinogenicity studies of Panax ginseng in Fischer 344 rats and B6C3F1 mice. Am J Chin Med 2011;39:779-88. https://doi.org/10.1142/S0192415X11009184
  27. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 2004;27:429-35. https://doi.org/10.1007/BF02980085
  28. Zhang Q, Kang X, Zhao W. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem Biophys Res Commun 2006;342:824-8. https://doi.org/10.1016/j.bbrc.2006.02.044
  29. Park EH, Kim YJ, Yamabe N, Park SH, Kim HK, Jang HJ, Kim JH, Cheon GJ, Ham J, Kang KS. Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell. J Ginseng Res 2014;38:22-7. https://doi.org/10.1016/j.jgr.2013.11.007
  30. Chen J, Peng H, Ou-Yang X, He X. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res 2008;18:322-9. https://doi.org/10.1097/CMR.0b013e32830b3536
  31. Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW, Park JH. Proteomic analysis of the anti-cancer effect of 20 S ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 2009;73:811-6. https://doi.org/10.1271/bbb.80637
  32. Gao Y, Li C, Wang Y, Liu Y, Li G, Fan X, Li Y, Tian J, Lee AW. Nonclinical safety of astilbin: a 4-week oral toxicity study in rats with genotoxicity, chromosomal aberration, and mammalian micronucleus tests. Food Chem Toxicol 2017;107(Pt A):1-9. https://doi.org/10.1016/j.fct.2017.06.024
  33. Kouitcheu Mabeku LB, Penlap BV, Kouam J, Essame O, Etoa FX. Toxicological evaluation of ethyl acetate extract of Cylicodiscus gabunensis stem bark (Mimosaceae). J Ethnopharmacol 2007;111:598-606. https://doi.org/10.1016/j.jep.2007.01.010

피인용 문헌

  1. Ginsenoside Rg3 Alleviates Complete Freund’s Adjuvant-Induced Rheumatoid Arthritis in Mice by Regulating CD4+CD25+Foxp3+Treg Cells vol.68, pp.17, 2020, https://doi.org/10.1021/acs.jafc.0c01473
  2. Anti-Angiogenic Properties of Ginsenoside Rg3 vol.25, pp.21, 2020, https://doi.org/10.3390/molecules25214905
  3. Acute oral toxicity of a novel functional drink based on Ilex guayusa, Vernonanthura patens, and cocoa husk vol.8, 2021, https://doi.org/10.1016/j.toxrep.2021.03.026
  4. Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys vol.122, 2021, https://doi.org/10.1016/j.yrtph.2021.104886
  5. Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action vol.169, 2021, https://doi.org/10.1016/j.phrs.2021.105647
  6. mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3 vol.146, 2020, https://doi.org/10.1016/j.biopha.2021.112608